These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 24403263)

  • 1. Ipilimumab and radiation therapy for melanoma brain metastases.
    Silk AW; Bassetti MF; West BT; Tsien CI; Lao CD
    Cancer Med; 2013 Dec; 2(6):899-906. PubMed ID: 24403263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.
    Knisely JP; Yu JB; Flanigan J; Sznol M; Kluger HM; Chiang VL
    J Neurosurg; 2012 Aug; 117(2):227-33. PubMed ID: 22702482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery.
    Mathew M; Tam M; Ott PA; Pavlick AC; Rush SC; Donahue BR; Golfinos JG; Parker EC; Huang PP; Narayana A
    Melanoma Res; 2013 Jun; 23(3):191-5. PubMed ID: 23462208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases.
    Patel KR; Shoukat S; Oliver DE; Chowdhary M; Rizzo M; Lawson DH; Khosa F; Liu Y; Khan MK
    Am J Clin Oncol; 2017 Oct; 40(5):444-450. PubMed ID: 26017484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of timing of stereotactic radiosurgery treatment of melanoma brain metastases treated with ipilimumab.
    Cohen-Inbar O; Shih HH; Xu Z; Schlesinger D; Sheehan JP
    J Neurosurg; 2017 Nov; 127(5):1007-1014. PubMed ID: 28059663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of melanoma patients with brain metastases treated with ipilimumab and stereotactic radiosurgery.
    Tazi K; Hathaway A; Chiuzan C; Shirai K
    Cancer Med; 2015 Jan; 4(1):1-6. PubMed ID: 25164960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic radiosurgery of early melanoma brain metastases after initiation of anti-CTLA-4 treatment is associated with improved intracranial control.
    An Y; Jiang W; Kim BYS; Qian JM; Tang C; Fang P; Logan J; D'Souza NM; Haydu LE; Wang XA; Hess KR; Kluger H; Glitza IC; Mahajan A; Welsh JW; Lin SH; Yu JB; Davies MA; Hwu P; Sulman EP; Brown PD; Chiang VLS; Li J
    Radiother Oncol; 2017 Oct; 125(1):80-88. PubMed ID: 28916225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRS in Combination With Ipilimumab: A Promising New Dimension for Treating Melanoma Brain Metastases.
    Khan M; Lin J; Liao G; Tian Y; Liang Y; Li R; Liu M; Yuan Y
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818798792. PubMed ID: 30213236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic radiosurgery for melanoma brain metastases in patients receiving ipilimumab: safety profile and efficacy of combined treatment.
    Kiess AP; Wolchok JD; Barker CA; Postow MA; Tabar V; Huse JT; Chan TA; Yamada Y; Beal K
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):368-75. PubMed ID: 25754629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ipilimumab and craniotomy in patients with melanoma and brain metastases: a case series.
    Jones PS; Cahill DP; Brastianos PK; Flaherty KT; Curry WT
    Neurosurg Focus; 2015 Mar; 38(3):E5. PubMed ID: 25727227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.
    Patel KR; Lawson DH; Kudchadkar RR; Carthon BC; Oliver DE; Okwan-Duodu D; Ahmed R; Khan MK
    Neuro Oncol; 2015 Oct; 17(10):1312-21. PubMed ID: 26014049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival of patients after ipilimumab and hypofractionated brain radiotherapy for brain metastases of malignant melanoma: sequence matters.
    Schmidberger H; Rapp M; Ebersberger A; Hey-Koch S; Loquai C; Grabbe S; Mayer A
    Strahlenther Onkol; 2018 Dec; 194(12):1144-1151. PubMed ID: 30298365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment.
    Anderson ES; Postow MA; Wolchok JD; Young RJ; Ballangrud Å; Chan TA; Yamada Y; Beal K
    J Immunother Cancer; 2017 Oct; 5(1):76. PubMed ID: 29037215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic melanoma to the brain: surgery and radiation is still the standard of care.
    Nicholas S; Mathios D; Jackson C; Lim M
    Curr Treat Options Oncol; 2013 Jun; 14(2):264-79. PubMed ID: 23504304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ipilimumab and whole brain radiation therapy for melanoma brain metastases.
    Gerber NK; Young RJ; Barker CA; Wolchok JD; Chan TA; Yamada Y; Friguglietti L; Beal K
    J Neurooncol; 2015 Jan; 121(1):159-65. PubMed ID: 25273687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
    Williams NL; Wuthrick EJ; Kim H; Palmer JD; Garg S; Eldredge-Hindy H; Daskalakis C; Feeney KJ; Mastrangelo MJ; Kim LJ; Sato T; Kendra KL; Olencki T; Liebner DA; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Dicker AP; Werner-Wasik M; Shi W
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):22-30. PubMed ID: 28816150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerance and outcomes of stereotactic radiosurgery combined with anti-programmed cell death-1 (pembrolizumab) for melanoma brain metastases.
    Nardin C; Mateus C; Texier M; Lanoy E; Hibat-Allah S; Ammari S; Robert C; Dhermain F
    Melanoma Res; 2018 Apr; 28(2):111-119. PubMed ID: 29356789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.